SCHEMBL1800870

SCHEMBL1800870

O=C(COCC(=O)Nc1ccc(-c2ccccc2)cc1C(=O)O)Nc1ccc(Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SERPINE1 P05121 5/20 0.53
▸ PTPN1 P18031 1/20 0.52
▸ GRIK1 P39086 1/20 0.52
▸ CNR1 P21554 3/20 0.50
▸ POLB P06746 2/20 0.50
▸ SUCNR1 Q9BXA5 1/20 0.50
▸ G6PD P11413 1/20 0.50
▸ CETP P11597 1/20 0.49
▸ ACLY P53396 2/20 0.49
▸ HCAR2 Q8TDS4 1/20 0.48
▸ PRSS12 P56730 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ MITF O75030 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1798637 0.90 KDM4E (0.52) SERPINE1GRIK1CNR1CETPKDM4E
SCHEMBL1799401 0.89 PTPN1 (0.64) SERPINE1PTPN1POLBG6PDACLY
SCHEMBL1797569 0.88 SERPINE1 (0.56) SERPINE1GRIK1POLBG6PDPRSS12
SCHEMBL1015269 0.85 GRIK1 (0.52) SERPINE1GRIK1POLBG6PDCETP
SCHEMBL1015135 0.84 GRIK1 (0.51) SERPINE1GRIK1POLBG6PDCETP
SCHEMBL1015619 0.84 SERPINE1 (0.49) SERPINE1GRIK1POLBG6PDCETP
SCHEMBL1015100 0.83 SERPINE1 (0.55) SERPINE1GRIK1CNR1POLBG6PD
SCHEMBL1800597 0.82 PTPN1 (0.56) SERPINE1PTPN1POLBHCAR2KDM4E
SCHEMBL1015946 0.82 SERPINE1 (0.54) SERPINE1GRIK1CNR1POLBG6PD
SCHEMBL1015034 0.81 SERPINE1 (0.69) SERPINE1GRIK1CNR1POLBG6PD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 — — US claimed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 — — US claimed
US-10092537-B2 Use for PAI-1 inhibitor RENASCIENCE CO., LTD. (JP) 2018-10-09 — — US disclosed
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2016-06-09 — — US disclosed
EP-2990057-A1 NOVEL USE FOR PAI-1 INHIBITOR Renascience Co., Ltd. (JP) 2016-03-02 — — EP disclosed
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 — — US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885PTPN1 3814/4885GRIK1 3308/4885
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885PTPN1 853/4885GRIK1 1873/4885
US-10092537-B2 Use for PAI-1 inhibitor SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885PTPN1 4113/4885GRIK1 3254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback